The participants were examined by a neurologist at baseline and after six.

A total of 44 patients were randomized to daily subcutaneous 20 – milligram injection of glatiramer acetate plus either an oral dose of 4 mg albuterol or placebo daily for two years received. The participants were examined by a neurologist at baseline and after six, 18 and 24 months, and blood samples were collected at the beginning and three, six and 12 months after initiation of the study. Magnetic resonance imaging of the brain at enrollment at enrollment, 12 and 24 months.

The authors note. In patients with multiple sclerosisAdding albuterol, a compound that treat commonly used to treat asthma and other respiratory diseases, to an existing treatment for patients with multiple sclerosis appears to improve clinical outcomes, according to a report in the September issue of Archives of Neurology, one of the JAMA / Archives journals.In its official letter the company declared that their decisions, that applying for this job retire on feedback from per the CHMP points out that of the Committee reached unlikely to a favorable opinion with without any additional efficacy data, that can not be guaranteed at that time depended.

Other articles from category "nutrition":

Random articles